Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. 2011;13(1):38–50.
Article PubMed PubMed Central Google Scholar
Arnold FJ, Cui Y, Michels S, Colwin MR, Stockford C, Ye W et al. TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS/FTD and related disorders. bioRxiv. 2024.
Zeng Y, Lovchykova A, Akiyama T, Liu C, Guo C, Jawahar VM et al. TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes. bioRxiv. 2024.
Bryce-Smith S, Brown AL, Mehta PR, Mattedi F, Mikheenko A, Barattucci S et al. TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTD. bioRxiv. 2024.
Alessandrini F, Wright M, Kurosaki T, Maquat LE, Kiskinis E. ALS-Associated TDP-43 Dysfunction Compromises UPF1-Dependent mRNA Metabolism Pathways Including Alternative Polyadenylation and 3`UTR Length. bioRxiv. 2024.
McKeever PM, Sababi AM, Sharma R, Khuu N, Xu Z, Shen SY et al. Single-nucleus multiomic atlas of frontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms. bioRxiv. 2023.
Mitschka S, Mayr C. Context-specific regulation and function of mRNA alternative polyadenylation. Nat Rev Mol Cell Biol. 2022;23(12):779–96.
Article PubMed PubMed Central CAS Google Scholar
Krus KL, Strickland A, Yamada Y, Devault L, Schmidt RE, Bloom AJ, et al. Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy. Cell Rep. 2022;39(13):111001.
Article PubMed PubMed Central CAS Google Scholar
Baughn MW, Melamed Z, López-Erauskin J, Beccari MS, Ling K, Zuberi A, et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science. 2023;379(6637):1140–9.
Article PubMed PubMed Central CAS Google Scholar
Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, et al. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130(5):643–60.
Article PubMed PubMed Central CAS Google Scholar
Wang R, Tian B. APAlyzer: a bioinformatics package for analysis of alternative polyadenylation isoforms. Bioinformatics. 2020;36(12):3907–9.
Article PubMed PubMed Central CAS Google Scholar
Riemenschneider H, Simonetti F, Sheth U, Katona E, Roth S, Hutten S, et al. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo. Acta Neuropathol Commun. 2023;11(1):112.
Article PubMed PubMed Central CAS Google Scholar
Imada EL, Wilks C, Langmead B, Marchionni L. REPAC: analysis of alternative polyadenylation from RNA-sequencing data. Genome Biol. 2023;24(1):22.
Article PubMed PubMed Central CAS Google Scholar
Amlie-Wolf A, Ryvkin P, Tong R, Dragomir I, Suh E, Xu Y, et al. Transcriptomic changes due to cytoplasmic TDP-43 expression reveal dysregulation of histone transcripts and nuclear chromatin. PLoS ONE. 2015;10(10):e0141836.
Article PubMed PubMed Central Google Scholar
Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216–21.
Article PubMed PubMed Central CAS Google Scholar
Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14(4):459–68.
Article PubMed PubMed Central CAS Google Scholar
Carmen-Orozco RP, Tsao W, Ye Y, Sinha IR, Chang K, Trinh VT, et al. Elevated nuclear TDP-43 induces constitutive exon skipping. Mol Neurodegener. 2024;19(1):45.
Article PubMed PubMed Central CAS Google Scholar
Hunter M, Spiller KJ, Dominique MA, Xu H, Hunter FW, Fang TC, et al. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery. Acta Neuropathol Commun. 2021;9(1):140.
Article PubMed PubMed Central CAS Google Scholar
San Gil R, Pascovici D, Venturato J, Brown-Wright H, Mehta P, Madrid San Martin L, et al. A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration. Nat Commun. 2024;15(1):1508.
Article PubMed PubMed Central CAS Google Scholar
Dafinca R, Barbagallo P, Farrimond L, Candalija A, Scaber J, Ababneh NA, et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-Derived motor neurons from patients with ALS/FTD. Stem Cell Rep. 2020;14(5):892–908.
Imaizumi K, Ideno H, Sato T, Morimoto S, Okano H. Pathogenic mutation of TDP-43 impairs RNA Processing in a cell type-specific manner: implications for the pathogenesis of ALS/FTLD. eNeuro. 2022;9(3).
Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22(2):167–79.
Article PubMed PubMed Central CAS Google Scholar
Ortuno D, Carlisle HJ, Miller S. Does inactivation of USP14 enhance degradation of proteasomal substrates that are associated with neurodegenerative diseases? F1000Res. 2016;5:137.
Article PubMed PubMed Central Google Scholar
Bellenguez C, Küçükali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022;54(4):412–36.
Article PubMed PubMed Central CAS Google Scholar
Montibeller L, Tan LY, Kim JK, Paul P, de Belleroche J. Tissue-selective regulation of protein homeostasis and unfolded protein response signalling in sporadic ALS. J Cell Mol Med. 2020;24(11):6055–69.
Article PubMed PubMed Central CAS Google Scholar
Wright EB, Larsen EG, Coloma-Roessle CM, Hart HR, Bhattacharya MRC. Transmembrane protein 184B (TMEM184B) promotes expression of synaptic gene networks in the mouse hippocampus. BMC Genomics. 2023;24(1):559.
Article PubMed PubMed Central CAS Google Scholar
Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117(2):137–49.
Comments (0)